Neutropenia during Revolade treatment in a patient with chronic ITP

SmPC updated with details of new paediatric indication: “Revolade is indicated for chronic immune thrombocytopenic purpura patients aged 1

Revolade is indicated for the treatment of paediatric patients aged 1 year and above with primary immune thrombocytopenia lasting 6 months or longer from

revolade REVOLADE GLAXOSMITHKLINE Click on a Brand to view Alternate Brands of same Drug dosage Retail Rs REVOLADE, [

revolade REVOLADE GLAXOSMITHKLINE Click on a Brand to view Alternate Brands of same Drug dosage Retail Rs REVOLADE, [